Treatment

CAPECITABINE, GEMCITABINE HYDROCHLORIDE, CISPLATIN clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic confirmatory (Phase III)
Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial)
This study looks at extra medicine (chemotherapy) after surgery for certain bile duct or gallbladder cancers. It compares a standard treatment to a new combination, hoping to stop the cancer from coming back and help people live longer and better.
For: Patients after curative intent resection of cholangiocarcinoma · (intrahepatic, hilar or distal) or muscle invasive gallbladder carcinoma · (without evidence of metastatic disease).
Austria · Germany · Italy